PRINCETON, N.J.--(BUSINESS WIRE)--
Bristol Myers Squibb
(NYSE: BMY) will announce results for the third quarter of 2024 on Thursday, October 31, 2024. Company executives will review financial results and address inquiries from investors and analysts during a conference call beginning at 8:00 a.m. ET on the same date.
Investors and the general public are invited to listen to a live webcast of the call at
http://investor.bms.com. Investors and the public can register for the live conference call
here. Those unable to register can access the live conference call by dialing in the U.S. toll free 1-833-816-1116 or international +1 412-317-0705. Materials related to the call will be available at
http://investor.bms.com
prior to the start of the conference call.
A replay of the webcast will be available at
http://investor.bms.com
approximately three hours after the conference call concludes. A replay of the conference call will be available beginning at 11:30 a.m. ET on October 31, 2024, through 11:30 a.m. ET on November 14, 2024, by dialing in the U.S. toll free 1-877-344-7529 or international +1 412-317-0088, conference code: 9624003.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at
BMS.com
or follow us on
LinkedIn,
X
(formerly Twitter),
YouTube,
Facebook, and
Instagram.
corporatefinancial-news
Source: Bristol Myers Squibb